Jones KB - Search Results

1

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells.

Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI. Salah Z, et al. Among authors: jones kb. Oncotarget. 2015 Mar 10;6(7):4920-35. doi: 10.18632/oncotarget.3025. Oncotarget. 2015. PMID: 25749032 Free PMC article.

2

Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.

Kurek KC, Del Mare S, Salah Z, Abdeen S, Sadiq H, Lee SH, Gaudio E, Zanesi N, Jones KB, DeYoung B, Amir G, Gebhardt M, Warman M, Stein GS, Stein JL, Lian JB, Aqeilan RI. Kurek KC, et al. Among authors: jones kb. Cancer Res. 2010 Jul 1;70(13):5577-86. doi: 10.1158/0008-5472.CAN-09-4602. Epub 2010 Jun 8. Cancer Res. 2010. PMID: 20530675 Free PMC article.

3

miRNA signatures associate with pathogenesis and progression of osteosarcoma.

Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan RI. Jones KB, et al. Cancer Res. 2012 Apr 1;72(7):1865-77. doi: 10.1158/0008-5472.CAN-11-2663. Epub 2012 Feb 20. Cancer Res. 2012. PMID: 22350417 Free PMC article.

4

Transposon mutagenesis disentangles osteosarcoma genetic drivers.

Jones KB. Jones KB. Nat Genet. 2015 Jun;47(6):564-5. doi: 10.1038/ng.3317. Nat Genet. 2015. PMID: 26018893

5

β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition.

Barrott JJ, Illum BE, Jin H, Zhu JF, Mosbruger T, Monument MJ, Smith-Fry K, Cable MG, Wang Y, Grossmann AH, Capecchi MR, Jones KB. Barrott JJ, et al. Among authors: jones kb. Oncotarget. 2015 Sep 8;6(26):22758-66. doi: 10.18632/oncotarget.4283. Oncotarget. 2015. PMID: 26259251 Free PMC article.

6

Metastatic pancreatic adenocarcinoma presenting as a large pelvic mass mimicking primary osteogenic sarcoma: a series of two patient cases.

Webber NP, Sharma S, Grossmann AH, Shaaban A, Jones KB, Layfield LJ, Randall RL. Webber NP, et al. Among authors: jones kb. J Clin Oncol. 2010 Oct 10;28(29):e545-9. doi: 10.1200/JCO.2010.28.6153. Epub 2010 Aug 16. J Clin Oncol. 2010. PMID: 20713877 Free PMC article. No abstract available.

7

At-risk populations for osteosarcoma: the syndromes and beyond.

Calvert GT, Randall RL, Jones KB, Cannon-Albright L, Lessnick S, Schiffman JD. Calvert GT, et al. Among authors: jones kb. Sarcoma. 2012;2012:152382. doi: 10.1155/2012/152382. Epub 2012 Mar 12. Sarcoma. 2012. PMID: 22550413 Free PMC article.

8

Molecular characterization of bone tumors and implications for treatment and prognosis.

Monument MJ, Jones KB. Monument MJ, et al. Among authors: jones kb. J Natl Compr Canc Netw. 2014 Feb;12(2):214-20. doi: 10.6004/jnccn.2014.0022. J Natl Compr Canc Netw. 2014. PMID: 24586083 Review.

9

MicroRNAs in osteosarcomagenesis.

Kafchinski LA, Jones KB. Kafchinski LA, et al. Among authors: jones kb. Adv Exp Med Biol. 2014;804:119-27. doi: 10.1007/978-3-319-04843-7_6. Adv Exp Med Biol. 2014. PMID: 24924171 Review.

10

Dendritic Cells Drive Osteosarcomagenesis through Newly Identified Oncogene and Tumor Suppressor.

Jones KB. Jones KB. Cancer Discov. 2019 Nov;9(11):1484-1486. doi: 10.1158/2159-8290.CD-19-0994. Cancer Discov. 2019. PMID: 31676561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page